Michelle Robertson
Director of Finance/CFO bij GERON CORPORATION
Vermogen: 791 046 $ op 31-03-2024
Profiel
Michelle Robertson is currently an Independent Director at Verastem, Inc. and will be the Chief Financial Officer, Treasurer & Executive VP at Geron Corp.
starting in 2023.
She was previously the Treasurer, Chief Financial & Accounting Officer at Momenta Pharmaceuticals, Inc. from 2017 to 2020, Head-Financial Planning & Analysis at Ironwood Pharmaceuticals, Inc. from 2012 to 2015, Vice President-Oncology Finance at Baxalta, Inc. in 2015-2016, and the Chief Financial Officer, Treasurer & Executive VP at Editas Medicine, Inc. from 2020 to 2023.
Ms. Robertson received her undergraduate degree from Bentley University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0.13% | 11-05-2023 | 106 610 ( 0.13% ) | 791 046 $ | 31-03-2024 |
GERON CORPORATION
-.--% | 01-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
VERASTEM, INC.
-.--% | 11-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Michelle Robertson
| Bedrijven | Functie | Begin |
|---|---|---|
| VERASTEM, INC. | Director/Board Member | 15-11-2021 |
| GERON CORPORATION | Director of Finance/CFO | 25-09-2023 |
Eerdere bekende functies van Michelle Robertson
| Bedrijven | Functie | Einde |
|---|---|---|
| EDITAS MEDICINE, INC. | Director of Finance/CFO | 17-05-2023 |
| MOMENTA PHARMACEUTICALS, INC. | Director of Finance/CFO | 08-01-2020 |
| BAXALTA INC | Corporate Officer/Principal | 01-01-2016 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Michelle Robertson
| Bentley University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| GERON CORPORATION | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
